ClinicalTrials.Veeva

Menu

A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients (FOCUS)

Cochlear logo

Cochlear

Status

Completed

Conditions

Hearing Impairment

Treatments

Device: Focused stimulation strategy
Device: ACE stimulation strategy

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

This feasibility study is designed to explore several facets of hearing performance that may show improvements for alternative modes of stimulation compared to Monopolar (MP) stimulation within a group of adult cochlear-implant recipients. Measures of speech recognition, music appreciation, listening effort, quality of life, and real-world assessments will be gathered to determine the most promising benefits for further examination.

Full description

Alternative modes of stimulation will be investigated that may improve spectral resolution through reduced cochlear spread of excitation and in turn provide enhanced speech perception and real-world clinical benefits over MP stimulation. The purpose of this feasibility study is to explore several facets of hearing performance that may show improvements with these alternative modes of stimulation compared to MP stimulation within a group of adult cochlear-implant recipients. Measures of speech recognition, music appreciation, listening effort, quality of life, and real-world assessments will be gathered to determine the most promising benefits for further examination. Individual neural, psychophysical, cognitive, and electrode placement data will also be obtained to inform questions related to across-subject variability, and practical aspects of power consumption and device fitting will be evaluated.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults 18 years of age or older.
  2. Candidate for unilateral cochlear implant with Slim Modiolar electrode array as determined by the implanting centre.
  3. English spoken as a primary language.
  4. Willingness to comply with all investigational requirements.
  5. Willing and able to provide written informed consent.

Exclusion criteria

  1. Previous or existing cochlear-implant recipient.
  2. Evidence of severe or greater sensorineural hearing loss prior to five years of age.
  3. Open-set pre-operative word score > 70% in the contralateral ear.
  4. Duration of severe to profound hearing loss > 20 years in the ear to be implanted.
  5. Adults with functional acoustic hearing in the ear to be implanted who desire to use an acoustic component in the implanted ear.
  6. Ossification or other cochlear anomaly that might prevent complete insertion of the electrode array.
  7. Hearing loss of neural or central origin.
  8. Medical or psychological conditions that would contraindicate undergoing surgery.
  9. Women who are pregnant.
  10. Additional handicaps that would prevent or restrict participation in the audiological evaluations.
  11. Unrealistic expectations on the part of the subject regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure and prosthetic device.
  12. Inability or unwillingness to use a hand-held device to control the sound processor and to collect test and survey data.
  13. Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
  14. Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  15. Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
  16. Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

19 participants in 2 patient groups

Adults cochlear implant recipients receiving alternative stimulation strategy
Experimental group
Description:
ACE strategy, 8 maxima, alternative mode
Treatment:
Device: Focused stimulation strategy
Adults cochlear implant recipients receiving Standard-of-Care stimulation strategy.
Active Comparator group
Description:
ACE strategy, 8 maxima, monopolar mode.
Treatment:
Device: ACE stimulation strategy

Trial contacts and locations

4

Loading...

Central trial contact

Ruth English; Herah Hansji

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems